The dengue-specific immune response and antibody identification with machine learning.
Eriberto Noel NataliAlexander HorstPatrick MeierVictor GreiffMario NuvoloneLmar Marie BabrakKatja FinkEnkelejda MihoPublished in: NPJ vaccines (2024)
Dengue virus poses a serious threat to global health and there is no specific therapeutic for it. Broadly neutralizing antibodies recognizing all serotypes may be an effective treatment. High-throughput adaptive immune receptor repertoire sequencing (AIRR-seq) and bioinformatic analysis enable in-depth understanding of the B-cell immune response. Here, we investigate the dengue antibody response with these technologies and apply machine learning to identify rare and underrepresented broadly neutralizing antibody sequences. Dengue immunization elicited the following signatures on the antibody repertoire: (i) an increase of CDR3 and germline gene diversity; (ii) a change in the antibody repertoire architecture by eliciting power-law network distributions and CDR3 enrichment in polar amino acids; (iii) an increase in the expression of JNK/Fos transcription factors and ribosomal proteins. Furthermore, we demonstrate the applicability of computational methods and machine learning to AIRR-seq datasets for neutralizing antibody candidate sequence identification. Antibody expression and functional assays have validated the obtained results.
Keyphrases
- dengue virus
- machine learning
- zika virus
- immune response
- aedes aegypti
- high throughput
- poor prognosis
- single cell
- global health
- genome wide
- transcription factor
- artificial intelligence
- amino acid
- big data
- binding protein
- signaling pathway
- gene expression
- cell death
- ionic liquid
- dna damage
- toll like receptor
- dna repair
- optical coherence tomography